source
- ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ optionAt a big meeting for weight loss drugs, Lilly’s “triple G” therapy set a new standard as lingering doubts surrounded other competing treatments.BioPharma Dive · 1mo ago↗ source
- STAT+: UnitedHealthcare’s lactation billing feud, and fake strokesThe biggest U.S. health insurer is changing how it pays for lactation counseling, and it could cut payment for many providers.STAT · 1mo ago↗ source
- STAT+: Novo underwhelmed by drug it once fought Pfizer forRevolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech newsSTAT · 1mo ago↗ source